NCT01770132View on ClinicalTrials.gov

Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 19, 2013

Primary Completion Date

July 13, 2017

Study Completion Date

October 28, 2018

Conditions
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage III Pancreatic Cancer
Interventions
DRUG

porfimer sodium

Given IV

PROCEDURE

endoscopic ultrasonography

Undergo EUS-PDT

PROCEDURE

photodynamic therapy

Undergo EUS-PDT

DRUG

gemcitabine hydrochloride

Given IV

Trial Locations (1)

46202

IU Simon Cancer Center, Indianapolis

Sponsors

Collaborators (1)

Pinnacle Biologics Inc.
All Listed Sponsors
collaborator

American Society for Gastrointestinal Endoscopy

OTHER

collaborator

Pinnacle Biologics Inc.

INDUSTRY

lead

John DeWitt

OTHER

NCT01770132 - Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter